Our firm is about people. That is our motto and that will always be our reality.
We do our best to get to know our clients, understand their situations, and get them the compensation they deserve.
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Without our team, we would’nt be able to provide our clients with anything close to the level of service they receive when they work with us.
The TorHoerman Law Team commits to the sincere belief that those injured by the misconduct of others, especially large corporate profit mongers, deserve justice for their injuries.
Our team is what has made TorHoerman Law a very special place since 2009.
Medtronic Spinal Cord Stimulator Lawsuit claims center on allegations that certain implanted pain devices may have malfunctioned, failed to work as intended, or caused complications that led to further medical intervention.
Spinal stimulator devices may be linked to serious injuries and complications including lead migration, loss of pain relief, painful or unintended stimulation, infection, device malfunction, and revision or explant surgery.
TorHoerman Law is reviewing claims involving injuries linked to spinal stimulator devices.
Medtronic manufactures spinal cord stimulation systems used to manage chronic pain in patients whose symptoms have not responded to medication, surgery, or other therapies.
These implantable systems deliver electrical stimulation to the spinal cord in an effort to alter how pain signals are processed before they reach the brain.
Spinal cord stimulation may be recommended for conditions such as complex regional pain syndrome, persistent nerve pain, or failed back surgery syndrome when other treatment options have not provided relief.
During the procedure, a spinal cord stimulator implanted system typically includes leads placed near the spinal cord and an implanted pulse generator that produces electrical stimulation.
Medtronic’s primary spinal cord stimulation platforms include the Intellis, Vanta, and Inceptiv systems.
These devices differ in features such as rechargeability, programming capabilities, and stimulation technology.
Newer systems like Inceptiv incorporate closed-loop technology designed to adjust stimulation based on biologic signals detected in the body.
Although spinal cord stimulators work for many patients seeking to relieve persistent pain, some individuals report spinal cord stimulator complications after implantation.
Reported issues in spinal cord stimulator cases have included loss of therapeutic benefit, lead migration, painful or unintended stimulation, infection, and the need for revision or explant surgery.
In more serious situations, patients allege that a spinal cord stimulator injury led to additional treatment, repeated procedures, or other medical problems after the device was implanted.
Some claims describe severe pain, nerve irritation, or other complications that allegedly developed after implantation, and in rare cases patients report severe injuries requiring further care.
Medtronic’s spinal cord stimulation systems differ from burst stimulation devices marketed by some other manufacturers.
Regardless of the stimulation technology used, spinal cord stimulator cases generally focus on whether a device performed as expected after implantation, whether risks were adequately disclosed, and whether the device contributed to complications experienced by the patient.
TorHoerman Law is reviewing claims involving Medtronic spinal cord stimulators for patients who experienced serious complications after implantation.
If you or a loved one experienced complications following spinal cord stimulator surgery, you may be eligible to pursue compensation through a Medtronic spinal cord stimulator lawsuit.
Contact TorHoerman Law for a free consultation.
Use the chatbot on this page for a free case review and to find out if you qualify.
As of early 2026, litigation involving Medtronic spinal cord stimulators is ongoing.
Individually filed lawsuits and newer complaints allege that design changes were not adequately disclosed and that patients were not properly warned about the risks associated with these devices.
These lawsuits generally allege that certain Medtronic spinal cord stimulators malfunctioned after implantation or created risks that went beyond the patient’s underlying pain condition.
Reported allegations include unintended electrical shocks, worsening pain, overheating that allegedly caused internal burns, and lead-related problems such as fracture or migration.
Reporting on spinal cord stimulator litigation also describes claims involving unsatisfactory pain relief, neurological complications, and the need for revision or removal surgery.
In broad terms, the lawsuits contend that manufacturers failed to conduct adequate safety testing and failed to provide necessary warnings about known or foreseeable risks.
Plaintiffs argue that those failures left patients vulnerable to severe injuries and additional medical treatment after implantation.
These allegations remain allegations unless proven in court or resolved through settlement.

Common themes in Medtronic spinal cord stimulator claims include:
These cases typically seek compensation for losses tied to the alleged device failure, including medical costs, pain and suffering, emotional distress, lost income, and the broader effect the complications had on the patient’s daily life.
Patients who experienced complications from an allegedly defective spinal cord stimulator may pursue compensation for those losses if the medical evidence supports the claim.
Eligibility does not necessarily depend on whether the device is still implanted, whether symptoms began immediately, or whether the manufacturer described a complication as rare.
What usually matters more is the specific device involved, the timing and nature of the symptoms, and the available records showing what happened after implantation.
Building a strong spinal cord stimulator case often requires detailed evidence, including operative reports, implant records, follow-up treatment notes, imaging, programming history, and records of any revision or removal procedure.
There is also older public enforcement history involving Medtronic’s neuromodulation business.
In 2015, Medtronic agreed to pay $2.8 million to resolve Department of Justice False Claims Act allegations related to SubQ stimulation procedures.
The government alleged that Medtronic caused certain physicians to submit false claims to federal healthcare programs; the matter was resolved without a determination of liability.
That settlement was not a spinal cord stimulator injury case, but it is part of the company’s publicly documented regulatory history.
Medtronic faces spinal cord stimulator lawsuits alleging that some of its spinal cord stimulation devices malfunctioned after implantation and caused serious harm.
Claims often describe painful electrical shocks, worsening pain, burns, and the need for additional surgery after a device was placed in the body.
Spinal cord stimulation devices are intended to treat chronic pain, but some patients allege that the implant created new injuries instead of improving function.
Spinal cord stimulator claims have also alleged lead fracture, lead migration, hardware failure, and neurological complications after spinal cord stimulator implantation.
A review of more than 107,000 medical device reports identified nearly 500 deaths, about 80,000 injury reports, and more than 30,000 malfunctions linked to spinal cord stimulator implantation and use.
The FDA’s MAUDE database itself is a repository of adverse event reports, but FDA guidance also explains that these reports can include incomplete, unverified, or duplicate information and do not by themselves prove causation.
Many patients say they were never fully informed about the risks of implantation, including the possibility of repeat procedures, worsening symptoms, or permanent injury.
When these systems fail, the medical consequences can be severe and can affect a patient’s mobility, pain level, and overall quality of life.

Potential injuries and complications may include:
A strong spinal cord stimulator claim usually depends on detailed evidence showing how the device failed and how the injury changed the patient’s life.
That often includes operative reports, imaging, follow-up treatment notes, revision records, and documentation of pain, lost function, and day-to-day limitations.
Eligibility does not necessarily hinge on whether the device is still implanted, whether symptoms started immediately, or whether the manufacturer described the problem as uncommon.
Patients who experienced complications after a spinal cord stimulator implantation may still have a viable claim if the records show that the device contributed to medical costs, physical pain, emotional distress, or other lasting losses.
Medtronic is one of the largest medical device manufacturers and one of the longest-established spinal cord stimulator manufacturers in this market.
FDA records show Medtronic’s implantable neurostimulation system for spinal cord stimulation was first approved in 1984, and the company’s current product lineup includes newer platforms with different battery and programming features.
Medtronic spinal cord stimulation systems are used to treat certain types of chronic, intractable pain, including chronic back pain and other persistent pain conditions affecting the trunk or limbs.
Current Medtronic product materials describe both rechargeable and recharge-free systems, as well as a newer closed-loop platform designed to adjust stimulation in real time.

Medtronic spinal stimulator models include:
Intellis Pro is a rechargeable spinal cord stimulation system that Medtronic says aids in the management of certain types of chronic, intractable pain.
Vanta is a recharge-free neurostimulation system for similar pain indications.
Inceptiv is a rechargeable spinal cord stimulator that Medtronic markets as a closed-loop system that adjusts in real time.
When a patient is reviewing a possible claim after a spinal cord stimulator operation, identifying the exact model matters.
Implant cards, operative reports, billing records, and follow-up notes may show whether the patient received an Intellis Pro, Vanta, or Inceptiv system, along with details about leads, programming, and any later service issues.
That information can become important when evaluating allegations involving device malfunction, battery problems, MRI restrictions, or complications after spinal cord stimulator placement.
Yes.
Medtronic has faced defective medical device lawsuit claims over its spinal cord stimulator devices.
Patients allege they suffered complications after implantation, including painful electrical shocks, worsening pain, loss of therapeutic benefit, and the need for revision or explant surgery.
Some claims also involve allegations of device migration, hardware problems, or abnormal stimulation after implantation.
These lawsuits generally argue that the device did not perform as intended or that patients and physicians were not adequately warned about potential risks.
Those allegations remain allegations unless proven in court or resolved through spinal cord stimulator verdicts or settlements.
You may have a potential claim if you received one of these modern spinal cord stimulators and later developed complications that went beyond the condition the device was supposed to treat.
In many cases, the main question is whether the system malfunctioned, failed to provide reliable therapy, or caused new problems after the medical devices implanted procedure.
A viable claim may involve allegations of painful shocks, loss of pain relief, infection, lead migration, or the need for revision or explant surgery.
Some patients also report symptoms affecting the spinal nerve root, worsening nerve pain, or other neurological problems after implantation.
In more serious cases, the records may describe alleged spinal cord compression, hardware failure, or complications tied to the leads or implantable pulse generator.

Qualification usually depends on the specific device used, when symptoms began, what follow-up records show, and whether additional treatment was required after implantation.
It can also matter whether the records clearly identify the manufacturer, whether the system was made by Medtronic, Boston Scientific, or another company, because product identification is central in these cases.
A lawyer reviewing a spinal stimulator lawsuit will usually look for operative reports, implant records, imaging, and later treatment notes to determine whether the facts support a claim.
Evidence is central in medical device litigation involving spinal cord stimulators because the case often turns on exactly what was implanted, how it performed over time, and what treatment followed.
In a Medtronic claim, the most important records usually begin with the operative report from the implantation procedure and the implant records generated at the time of surgery.
Product identification cards, model and serial numbers, and billing documents may help show whether the case involves an Intellis, Vanta, or Inceptiv system.
That product-specific identification matters because many spinal cord stimulators have different recharge features, programming functions, and service histories.
Records from later treatment may also help show whether the spinal cord stimulator developed performance issues after implantation.
Imaging can be important where it documents lead migration or another hardware problem.
Programming history and charging-related records may also be relevant where a patient alleges ineffective pain relief, abnormal stimulation, or repeated attempts to restore therapy after the device malfunctioned.
Revision records, explant records, and symptom documentation before and after implantation can help show whether the patient faced debilitating pain, severe pain, nerve damage, or other complications after the device was placed.
Notes from physical therapy and other pain management treatments may also help establish how the symptoms changed over time and whether the patient had to abandon other pain management treatments after the implant failed to deliver significant pain relief.

Evidence that may matter in these cases includes:
Damages in defective medical device cases are based on the actual harm and losses tied to the implanted device.
In Medtronic spinal cord stimulator cases, that may include past and future medical expenses, the cost of revision or explant surgery, and other treatment required after the device allegedly caused serious complications.
Some patients also seek recovery for lost income when worsening chronic pain, chronic nerve pain, or additional surgery prevents them from working.
Non-economic damages may include physical pain, pain and suffering, reduced quality of life, and long-term disability, especially where the patient alleges spinal cord injuries, nerve damage, or lasting limitations after exposure to abnormal electrical impulses or repeated electrical shocks.
In some cases, the value of the claim may also be affected by how many additional procedures were required and whether the patient continued to experience inadequate pain relief after surgery.
Case value depends on the specific facts, including the device model, the severity of the injury, the number of additional procedures, and the long-term effect on the patient’s daily life.
No outcome is guaranteed.
Prior results, clinical trials, or product materials from the medical device industry do not determine the value of any individual claim.

Potential damages in these cases may include:
TorHoerman Law is reviewing claims from people who received Medtronic spinal cord stimulators and later experienced major complications, painful electrical shocks, device failure, or revision or removal surgery.
These claims may involve allegations that a device intended to alleviate chronic pain instead caused additional treatment, persistent symptoms, or other serious harm after implantation.
Our firm is investigating spinal cord lawsuit claims by reviewing implant records, surgical records, imaging, programming history, and other medical documentation.
That review may help determine whether a patient’s case involves lead migration, device malfunction, inadequate pain relief, or another substantial injury connected to one of these systems.

We understand that patients may be dealing with severe complications after a procedure that was supposed to improve function and reduce pain.
If you believe a Medtronic spinal cord stimulator harmed you, contact TorHoerman Law for a free case review.
You can also use the chatbot on this page to see if you qualify today.
The Medtronic models most likely to be relevant on this page are Intellis, Vanta, and Inceptiv.
Medtronic describes Intellis and Vanta as spinal cord stimulation systems used to manage chronic, intractable pain, and the company announced FDA approval for Inceptiv as a closed-loop spinal cord stimulator that adjusts stimulation in real time.
That said, eligibility does not depend on the product name alone.
It usually depends on the exact implanted system, the component involved, the timing of symptoms, and what the operative report, implant card, billing records, and follow-up medical records show.
Yes.
FDA recall records show that Medtronic spinal cord stimulator products have been subject to multiple Class II recalls, including recalls involving the Intellis and Vanta platforms.
In 2021, the FDA posted a Class II recall for the Intellis Model 97755 Recharger because of a potential for unintended heating while charging certain Intellis neurostimulators.
The FDA also posted a 2021 Class II recall for the Intellis Spinal Cord Stimulator clinician application because a software issue could make clinicians unable to program the implanted device.
In 2022, the FDA posted a Class II recall for certain Vanta implantable neurostimulators because the device could fail to communicate with the clinician or patient programmer system, and in 2024 the FDA posted another Class II recall for Medtronic Vanta involving faster-than-expected battery depletion that could lead to earlier outpatient reprogramming or surgical replacement.
A recall does not automatically create a lawsuit, but it can become important evidence when the recalled issue matches the patient’s implanted device, symptoms, and later treatment.
Current lawsuit reporting and broader spinal cord stimulator allegations describe several recurring complication themes involving Medtronic devices.
These include unnecessary or painful electrical shocks, loss of pain relief, device malfunction, lead migration, infection, and the need for revision or explant surgery.
Public recall history also reflects performance-related issues involving Medtronic spinal cord stimulation products and accessories, including Vanta battery longevity concerns and earlier recharger-related problems affecting Intellis systems.
Those records do not prove that a device defect caused any individual patient’s injury, but they help show the kinds of performance problems that have been publicly documented.
Possibly, yes.
Revision or explant surgery is one of the clearest facts that may support a claim because it can help show that the patient experienced a serious device-related problem after implantation.
That is especially true when the records also document malfunction, persistent pain, unintended shocks, failed therapy, infection, or another major complication.
That still does not guarantee a viable case.
The claim depends on the medical records, the specific implanted system, the surrounding facts, and whether the evidence ties the complication to the device rather than the underlying pain condition being treated.
No.
A recall does not automatically create a legal claim, and it does not by itself prove that Medtronic is legally liable in any individual case.
A recall may still become important evidence when it is combined with proof that the patient received the affected device, experienced a malfunction or injury, and required additional medical treatment.
In other words, the recall can matter, but the strength of the case still depends on the patient’s implant records, symptoms, and treatment history.
Owner & Attorney - TorHoerman Law
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.
In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.
In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.
In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.
In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?